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Abstract 
Bayesian networks (BNs) are rapidly becoming a leading tool for applied Artificial Intelligence. 
Although BNs have been used successfully for many medical diagnosis problems, there have been 
few applications to epidemiological data where data mining methods play a significant role. In this 
paper, we look at the application of BNs to epidemiological data, specifically assessment of risk for 
coronary heart disease (CHD). We build the BNs: (1) by knowledge engineering BNs from two 
epidemiological models of CHD in the literature; (2) by applying a causal BN learner. We evaluate 
these BNs using cross-validation. We compared performance in predicting CHD events over 10 
years, measuring area under the ROC curve and Bayesian information reward. The knowledge 
engineered BNs performed as well as logistic regression, while being easier to interpret. These BNs 
will serve as the baseline in future efforts to extend BN technology to better handle epidemiological 
data, specifically to model CHD. 
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1 Introduction 
Bayesian networks (BNs) are rap-
idly becoming a leading tool for ap-
plied Artificial Intelligence (AI).  The 
development of BNs and associated 
algorithms in the 1980s by Pearl 
(1988), Lauritzen and Spiegelhalter 
(1988) and others has made proper 
probabilistic reasoning a real option 
for a large variety of AI applications. 
In general, probability calculations are 
computationally intractable (Cooper, 
1990), which fact led early expert sys-
tems to use a variety of simplifications, 
including fuzzy logic, certainty factors, 
and PROSPECTOR’s rule-based ap-
proach (Shafer and Pearl, 1990). These 
systems, from the probabilistic point 
of view, all invoke strong independ-
ence constraints (see Heckerman, 
1986; Neapolitan, 1990). BNs can rep-
resent arbitrary probability distribu-
tions, and so overcome the limits of 
these independence assumptions; at the 
same time BNs can take advantage of 
any simplifications possible given any 
real independencies in the application 
domain. There are now good tech-
niques for learning either discrete or 
Gaussian Bayesian networks (although 
few methods for learning hybrid net-
works).  Furthermore, BNs provide a 
natural causal interpretation (unlike 
artificial neural nets and classification 
trees) and so are a fruitful method for 
building expert systems with human 
input.  They can easily combine both 
expert knowledge and data mining. 
 There have been many medical ap-
plications of BNs (see Korb and 
Nicholson, 2004, for a recent survey), 
however few applying data mining 
methods to epidemiology. In this pa-
per, we look at such an application to 
epidemiological data, specifically as-
sessment of risk for coronary heart dis-
ease (CHD). CHD comprises acute 
coronary events including myocardial 
infarction (heart attack) but excluding 
stroke. Superior predictions of cardio-
vascular deaths would allow for better 
allocation of health care resources and 
improved outcomes.  Amid burgeon-
ing healthcare costs (A$1 billion is 
currently spent on anti-lipid and anti- 
hypertensive medication), cost effec-
tiveness has become a dominant 
consideration for determining which 
preventive strategies are most appro-
priate.  In Section 2 we provide an in-
troduction to BNs, their application to 
medical domains and the BN software 
we use to present examples. 
We have built BNs for predicting 
CHD in two ways.  First, we knowl-
edge engineered BNs from the medi-
cal literature.  Generally, “knowledge 
engineering” means converting expert Twardy et al. | electronic Journal of Health Informatics 1(1): e3 
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2 Bayesian Networks 
2.1 What is a Bayesian 
Network? 
A Bayesian network is a graph with 
arcs connecting nodes and no directed 
cycles (i.e., a directed acyclic graph or 
dag), whose nodes represent random 
variables and whose arcs represent di-
rect dependencies.  Each node has a 
conditional probability table (CPT), 
which, for each combination of values 
of the parents, gives the conditional 
probability of each of its values. The 
CPTs quantify the relationship between 
connected variables. Users can set the 
values of any combination of nodes in 
the network that they have observed. 
This evidence propagates through the 
network, producing a new probability 
distribution over all the variables in 
the network.  There are a number of 
efficient exact and approximate infer-
ence algorithms for performing this 
probabilistic updating (Pearl, 1988), 
providing a powerful combination of 
predictive, diagnostic and explanatory 
reasoning. 
Consider the following simple ex-
ample of a medical diagnostic prob-
lem, namely for metastatic cancer. 
(This example has a long history in 
the literature, described in Korb and 
Nicholson, 2004.) 
Example statement: Metastatic 
cancer is a possible cause of brain 
tumors and is also an explanation for 
increased total serum calcium. In turn, 
either of these could explain a patient 
falling into a coma. Severe headache 
is also  associated with  brain tumors. 
Figure 1 shows a Bayesian network 
model of this medical diagnosis prob-
lem, with a parameterization (i.e. the 
CPTs).  This model includes five 
Boolean variables, each represented by 
a node that can take the values True 
(T) or False (F). The nodes are con-
nected by arcs, with the direction of 
the arc indicating a causal relationship; 
for example, a coma may be caused by 
either a brain tumour (node B) or in-
creased total serum calcium (node S). 
The relationship between connected 
nodes is quantified by the CPT, where 
each entry shows the probability of the 
child node having a particular value, 
given a combination of values of the 
parent nodes.  BN parameters, there-
fore, have a natural interpretation as 
the probability of a cause bringing 
about an effect, so long as arcs respect 
causal order. For example, given in-
creased total serum calcium, but no 
brain tumour, the probability of the 
patient going into a coma is modeled 
by the CPT entry 
P(C=T|S=T,B=F)=0.8. Nodes without 
parents have prior probabilities; here 
the prior for metastatic cancer is 0.2. 
2.2 Reasoning with 
Bayesian Networks 
Given the specification of a BN, we 
can compute posterior probability dis-
knowledge into a computer model. 
Here, rather than querying experts di-
rectly for information required to build 
a BN, we used existing epidemiologi-
cal models of CHD.  In Section 3 we 
describe the construction of two such 
BNs using: (1) a regression model from 
the Australian Busselton study 
(Knuiman et al., 1998) and (2) a sim-
plified “points-based” model from the 
German PROCAM study (Assmann et 
al., 2002).  We also adapted both BNs 
for evaluation on the raw Busselton 
data.  Second, we have applied a causal 
discovery program, CaMML (Wallace 
and Korb, 1999; Wallace et al., 2005), 
described in Section 4. 
We then evaluated these BNs, com-
paring them to each other and to a suite 
of other machine learning methods 
(Section 5).  We compare performance 
predicting CHD events over 10 years, 
measuring area under the ROC curve 
(AUC) and Bayesian information re-
ward (BIR). The knowledge-engi-
neered BNs performed as well as 
logistic regression, which was consist-
ently the top machine-learner, getting 
the best AUC of about 0.844 and equal- 
best results for BIR. These BNs will 
serve as baseline predictors in an ARC 
funded project to extend BN technol-
ogy to better handle epidemiological 
data, specifically to model CHD. 
Figure 1: A simple Bayesian 
network model for the metastatic 
cancer problem: structure and 
CPTs. 
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tributions for each of the nodes; these 
are often called “beliefs”. Figure 2(a) 
shows the beliefs when no observa-
tional evidence has been obtained, im-
plemented in the BN software Netica 
(Norsys, 2000). For readers unfamil-
iar with Netica’s interface, each “box” 
shows a node in the network, with the 
variable label in the bar across the top 
(e.g. C, for Coma).  The possible dis-
crete states of the variable are shown 
in the left most column (e.g. True and 
False). The box also shows the poste-
rior probability distribution given the 
evidence entered so far (if any).  It rep-
resents the probabilities as both a per-
centage (e.g. 61.6 and 38.4) and a 
histogram. 
Specifying the value of a variable 
(e.g. test result or clinical observation) 
would provide us with a revised diag-
nosis and expected value for all the 
other variables.  Figure 2(b) shows the 
updated beliefs given the observation 
the patient is in a coma, shown with 
C=T set to 100%. We can see that the 
diagnosis of the patient having meta-
static cancer has increased from the 
prior of 0.2, to 0.425. (Recall that 
Netica presents the probabilities as 
percentages.) This is an example of 
diagnostic reasoning – from observa-
tion of symptoms to the probability of 
causes. 
Figure 2(c) shows the results when a 
different symptom is observed, namely 
that the patient complains of a head-
ache (i.e., H=True). The belief in meta-
static cancer is lower, 0.208, as head-
aches are less of an indicator. Figure 
2(d) shows the results after both ob-
servations are added. The posterior 
probability of metastatic cancer has in-
creased further to 0.43; this shows the 
power of BNs for incremental reason-
ing and combining evidence. 
Figure 2(e) shows a different use of 
BNs, namely predictive reasoning. 
Evidence has been added of metastatic 
cancer (i.e. M=T), which changes the 
probability of all the other nodes, “de-
scendents” of M in the network. For 
example, the probability that the pa-
tient is in a coma has risen from 0.32 
to 0.68. 
Figure 2(f) shows an example of the 
BN reasoning with information about 
Figure 2: Reasoning with Bayesian networks. Posterior probabilities, or “beliefs” computed from the BN 
for a range of scenarios: (a) no information available, hence prior belief;. (b) (c) & (d) diagnostic 
reasoning; (e) predictive reasoning (f) “mixed mode” reasoning (both cause and symptom observed). 
 
(a) No evidence  (b) Coma observed (C=T) 
 
(c) Headaches reported (H=T) 
 
(d) Both Coma and Headaches (C=T,H=T) 
(e) Patient known to have metastatic cancer 
(M=T) 
(f) Patient has metastatic cancer, but not in 
coma (M=T, C=F) 
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both causes and symptoms, so-called 
“mixed mode” reasoning. The patient 
has metastatic cancer, but is not in a 
coma. Beliefs in both S (increased to-
tal serum calcium) and B (brain tu-
mour) have decreased, compared to the 
case in Figure 2(e), with this additional 
evidence. 
This set of simple cases illustrates 
the power of BNs for modeling causal 
problems. BNs can be used for many 
types of reasoning: diagnostic, predic-
tive, mixed mode or incremental, as 
evidence can be added to nodes any-
where in the network, in any order. 
Because BNs are graphs, they can be 
used to model all relationships between 
variables. Hence, they are a much more 
powerful modeling method than tradi-
tional statistical models. For example, 
relationships between predictor vari-
ables are not allowed in logistic re-
gression models. In addition, Bayesian 
networks, via their CPTs (or other func-
tional models of parent-child relation-
ships), can represent both linear and 
non-linear causal relationships, includ-
ing causal interactions. Linear BNs are 
a form of path model, generalizing 
(subsuming) the common linear regres-
sion models. 
BNs are not limited to reasoning 
about observational data: they can also 
be used to model and reason about 
causal interventions (e.g., experimen-
tation). While standard BNs provide 
probabilities, common extensions to 
BNs support decision-theoretic deci-
sion making, using decision and util-
ity nodes. For example, in the medical 
domain, such so-called decision net-
works can be used to decide whether 
to run tests or undertake treatments, 
where the decision making combines 
both the probabilities and cost-benefit 
models (see Korb and Nicholson, 
2004). 
2.3 Building Bayesian 
Networks 
BNs can be either hand-crafted or 
machine learned. Traditional knowl-
edge engineering methods build expert 
systems by hand-crafting the BN to 
match expert knowledge, one probabil-
ity at a time. This is a very slow and 
tedious process, so limiting that it has 
been dubbed the knowledge bottle-
neck (e.g., Gaag et al., 1999). Auto-
mated learning methods are necessary 
to break through the bottleneck. One 
hybrid approach is to have experts 
specify the structure and the computer 
learn the parameters from data. But in 
many cases the correct model is not 
known, or there are unknown missing 
variables leading the resultant model 
to be a poor predictor. Fully automated 
methods learn both the structure and 
the parameters. If the network is com-
posed entirely of discrete nodes or en-
tirely of continuous nodes, there are 
several established methods and 
metrics. In theory a BN is defined for 
any combination of variable types. In 
practice, BNs are either all continuous 
or all discrete, because we lack the al-
gorithms for combining these types of 
distributions efficiently. Some work 
has been done on handling inference 
in special cases and some work has 
been done on learning parameters in 
hybrid networks; general structure 
learning of hybrid networks remains 
an unsolved problem and is one of the 
future directions for our project. 
2.4 Bayesian Networks in 
Epidemiology 
Although AI researchers in the late 
1980s demonstrated the superior flex-
ibility of BNs over previous methods 
for medical expert systems 
(Heckerman, 1986), and despite the 
success of many example BNs in pa-
thology and diagnosis (see Heckerman, 
1990, and Jensen et al., 1987, for two 
of the most prominent examples), there 
have been relatively few deployed ap-
plications of BNs to medical problems. 
Two such applications are the general 
diagnostic QMR — Quick Medical 
Reference — project whose 
probabilistic descendant QMR-DT 
(Shwe et al., 1991) is at least studied 
by medical researchers and the newer 
PROMEDAS project in the Nether-
lands (Foundation for Neural Networks 
and University Medical Centre 
Utrecht, 2002).  But both QMR-DT 
and PROMEDAS rely heavily on tra-
ditional knowledge engineering and 
are mostly hand-crafted from the lit-
erature with extensive consultation 
with medical experts. Those two 
projects also focus on automating ex-
pert diagnosis, not on discovering new 
connections via data mining. 
3 Knowledge 
Engineering BNs from 
the Literature 
In this section we first describe the 
two epidemiological models of CHD 
selected from the literature: (1) a re-
gression model from the Australian 
Busselton study (Knuiman et al., 1998) 
and (2) a simplified “points-based” 
model from the German PROCAM 
study (Assmann et al., 2002).  Bayesian 
networks are flexible enough represen-
tations for us to reimplement both as 
BNs.  We describe briefly how we con-
structed these BNs, although for rea-
sons of space we refer the reader to 
Twardy et al. (2005) for full details. 
3.1 CHD Model from 
Busselton study 
Busselton is a town south of Perth in 
Western Australia. The Busselton study 
(Busselton Health Study Group, 2004) 
collected baseline data every three 
years from 1966 to 1981 and has re-
sulted in hundreds of papers on car-
diovascular disease, respiratory 
disease, total mortality, hospital admis-
sion rates, and familial aggregation of 
risk factors.  Mortality followup is 
done via linkage to the Death Register 
for Western Australia, and manually 
(Busselton Health Study Group, 2004). 
The Busselton database includes both 
cross-sectional and followup data and 
has over 8,000 participants. Therefore, 
unlike many applications of BNs, we 
have enough data for parameter learn-
ing. 
We use Knuiman et al.’s epidemio-
logical model of CHD (Knuiman et al., 
1998), which presented the first Aus-
tralian multivariate CHD risk score. 
Like most CHD models, they used a 
form of regression, in this case a Cox 
proportional-hazards model. Where 
logistic regression predicts the binary 
variable reporting CHD events after a Twardy et al. | electronic Journal of Health Informatics 1(1): e3 
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fixed period of time (usually 10 years), 
a Cox model uses the times of each 
CHD event to estimate risk.  The re-
sult is still a regression, where risk fac-
tors are assumed to act independently. 
Therefore the structure of the model is 
a series of independent predictors lead-
ing to the target variable. 
Knuiman et al. used 2,258 people 
from the 1978 cohort: those aged 40– 
79 who had data on all the required 
variables. (There were about 4000 peo-
ple in the 1978 cohort, about 1460 of 
whom were under the age of 40, and 
about 100 over 79.) The authors re-
port 98% followup for their subset. The 
base rate for CHD events was about 
23% for men (243 out of 1,036) and 
14% for women (172 out of 1,222). 
They considered 13 predictors (plus 
sex), but discarded Body Mass Index, 
Atrial Fibrillation, and Drinking as 
uninformative, leaving 10 predictors. 
They then combined Total Cholesterol 
and HDL into the ratio of HDL to To-
tal, leaving 9. 
3.2 CHD Model from 
PROCAM study 
The Prospective Cardiovascular 
Münster study, or PROCAM, ran from 
1979 to 1985, with followup by ques-
tionnaire every two years. There are 
several papers on PROCAM, e.g., 
(Assmann et al., 1998; Cullen et al., 
1997). PROCAM appears to have re-
cruited over 25,000 patients, although 
the estimates are not entirely consist-
ent, and many of the studies use only 
subsets. 
Assman et al. created a logistic re-
gression model from about 25,000 
cases (about 8,000 women) to predict 
8-year risk of a cardiovascular event 
(CHD8) (Assmann et al., 1998). The 
PROCAM group had lower absolute 
risk levels than predicted by the 
Framingham model (Hense et al., 
2003). More recently, Voss et al. (2002) 
used only “5159 men aged 35–65 years 
recruited before the end of 1985,” 
claiming that “among women and 
younger men, numbers were insuffi-
cient” to permit 10-year longitudinal 
analysis (Voss et al., 2002, p. 1254). 
They showed that an artificial neural 
network (ANN) surpassed logistic re-
gression. 
Here we use Assman et al.’s much 
simpler PROCAM model (Assmann et 
al., 2002).  They showed that their sim-
ple scoring system performed as well 
as the 8-variable Cox proportional haz-
ards model on which it was based. The 
task is to predict the 10-year incidence 
of CHD events (CHD10) in about 
5,000 men, aged 35–65 at recruitment. 
There were 325 acute coronary events 
during that time, so the base rate is 
about 6%. The area under the ROC 
curve was 0.824, compared with 0.829 
for the Cox model. 
3.3 Overview of the KE 
process 
Building a BN for a particular ap-
plication domain involves three tasks: 
1.  identification of the important 
variables, and their values; 
2.  identification and representa-
tion of the relationships be-
tween variables in the network 
structure; and 
3.  parameterization of the net-
work, i.e., determining the con-
ditional probability tables 
associated with each network 
node. 
In our CHD application, the 
parameterization step is complicated 
by the fact that although many of the 
predictor variables are continuous, our 
BN software requires them to be 
discretized.  We divided the process 
into: 
(3a)   discretization of predictor vari-
ables; 
(3b)   parameterization of the predic-
tor variables; 
(3c)  parameterization of the target 
variables. 
We used the BN software package 
Netica (Norsys, 2000), but the ap-
proach applies to any system allowing 
equations to specify the probability 
distributions for each node. It is worth 
pointing out that this requirement to 
discretize all variables is a limitation 
of current BN technology and does 
handicap the predictive power of the 
BN compared to methods that can 
work with continuous variables such 
as logistic regression. 
3.4 The Busselton BN 
Structure.  Knuiman et al. (1998) 
described risks separately for men and 
women. Rather than make two sepa-
rate networks, we made Sex the sole 
root node in the BN, with most other 
nodes dependent on it. To match their 
model, we created a node for the HDL/ 
Total ratio, which is the child of HDL 
and Total Cholesterol. The clinician 
should not care about this ratio node, 
as it is just a piece of calculating ma-
chinery; it is straightforward to hide it, 
as we have done in Figure 3. 
Figure 3(a) shows the Busselton net-
work, where each “box” is a node and 
nodes are connected by arcs; the CPTs, 
quantifying the relationship between 
the connected nodes, are not shown. 
As we can see from the BN structure, 
the predictors all determine the 10-year 
risk of CHD event, which is in turn 
reduced to a yes/no prediction of a 
coronary heart disease event, repre-
sented by node CHD10. In the BN in 
Figure 3(a), we can see that evidence 
has been entered for Sex=male, as the 
probability of male is 1. The target 
node CHD10 is enlarged in the lower 
right of the figure. Clinicians may well 
prefer the 10-year risk to the binary 
CHD10, as the former gives a much 
better idea about the uncertainty of the 
estimate. Indeed, this is one of the ben-
efits of using BNs. Without knowing 
anything else about a patient, this net-
work predicts that the probability of a 
CHD event after 10 years for a male is 
0.226. Figure 3(b) shows a particular 
case (with the 10-year risk node hid-
den); here the predicted probability of 
a CHD event has risen to 0.373. 
Priors for Predictor variables. 
Knuiman et al. reported summary sta-
tistics for their predictors. These be-
come the priors for our population: one 
set for men and another for women. 
We generated parametric or multi-state 
priors from their summary statistics. 
The priors for the multi-state variables 
were entered as tables. The priors for 
continuous variables were specified 
using the BN software’s equation fa-Twardy et al. | electronic Journal of Health Informatics 1(1): e3 
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cility, assuming they were Gaussian 
distributions. 
Discretization. Five predictors (or 
seven, if counting BMI and Ratio) are 
continuous variables.  The 
discretization levels are seen in the 
values for each node in the BN of Fig-
ure 3.  For example, Knuiman et al. 
rejected those with baseline age < 40 
or e>=80, setting the bounds.  To be 
practical, we chose 5-year divisions 
within that range  giving the Age node 
bins of {40-45, 45-50, 50-55, 55-60, 
60-65, 65-70, 70-75, 75-80}.  A de-
tailed discussion of these discretization 
choices is given in (Twardy et al., 
2005). 
Parameterizing the Target Vari-
ables. Score is a continuous variable 
which is the weighted sum of all the 
predictor scores. The weights corre-
spond to the Cox proportional hazards 
regression, and are taken from 
Knuiman et al. (1998). We have sepa-
rate equations for men and women (see 
Twardy et al., 2005, for details).  To 
Figure 3: (a) The Busselton BN showing the prior distribution for males. The target node CHD is on the right. 
(b) A simplified view of the Busselton network, without the Risk node, showing a hypothetical case. 
(a) 
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parameterize the Risk node, we fit a 
Weibull curve to Knuiman et al.’s Fig-
ure 3. 
3.5 The PROCAM BNs 
Structure. The PROCAM BN struc-
ture is shown in Figure 4(a). Essen-
tially, the PROCAM score  is a 
weighted sum of the 8 risk factors. 
There is one root node for each risk 
factor. Each of these root nodes has in 
turn one child, which is the associated 
scoring node. For example, there is an 
arc from the Age root node to its asso-
ciated score node AgeScore. The 8 
score nodes are all parents of the 
PROCAM score. This combined score 
node is then a parent of the 10 year 
risk node. However, although the scor-
ing scheme was designed to be sim-
pler than logistic regressions, the extra 
scoring nodes complicate the BN.  Fig-
ure 4(b) shows the essential structure 
Figure 4: The PROCAM BN showing 10-year risk (a) No evidence added. (b) Evidence entered for a 
particular case, with Score nodes hidden. 
(a) 
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– 8 nodes converging on a final score 
— obtained by “absorbing”  the score 
nodes, for a particular case. We can 
see that the probability of a 10-year 
risk of 10%-20% has risen from 0.115 
to 0.929. 
Priors for predictor variables. 
Assmann et al. (2002) reported sum-
mary statistics for their predictors. We 
generated parametric or multi-state pri-
ors as appropriate (see Twardy et al., 
2005, for details). 
Discretization. The discretization 
levels were given for us in Assmann et 
al. (2002); the corresponding levels in 
the BN can be seen in Figure 4. Age is 
in 5-year bins (groups), as in our 
Busselton network. 
Points. The Score nodes (AgeScore 
etc.) assign point values to each of the 
levels of the predictors. These are small 
integers, mostly [0, 10]. 
Target variables. PROCAM Score 
is a continuous variable which is the 
sum of all the individual predictor 
scores.  The work comes in translating 
this to probabilities. All these risk 
models have a sigmoid component to 
convert the risk score to a real risk. 
Therefore we can fit a logistic equa-
tion (we used the Verhulst equation) 
to “Table 4, Risk of Acute Coronary 
Events Associated with Each 
PROCAM Score” (Assmann et al., 
2002). This table tops out at e>=30, 
and is much finer near the bottom; we 
defined the following levels for the 
risk: (0, 1, 2, 5, 10, 20, 40, 100). The 
fit is good over the data range, (20,60), 
and tops out at a 70% risk of an event 
in the next 10 years, no matter how 
high the PROCAM score goes.  As 
there is always some unexplained vari-
ability, our domain experts consider 
this reasonable (Liew and Rogers, 
2004). To define the risk in the BN, 
we made “Risk” a child of “Score” and 
set its equation using the fitted param-
eters. 
Comparing Busselton and 
PROCAM BNs. We note basic dif-
ferences between the Busselton and 
PROCAM models. Most obviously, the 
PROCAM BN does not include Sex, 
modeling males only. It also omits 
DBP, AHT, CHD, and LVH, but in-
cludes Family History. Instead of the 
ratio of HDL to total cholesterol, it uses 
HDL, LDL, and Triglycerides indi-
vidually. The PROCAM discretization, 
taken from the paper, is usually slightly 
finer than the one adopted for the 
Busselton BN. 
The adapted PROCAM BN. We 
also wanted to know how well this sim-
ple PROCAM BN predicts the 
Busselton data. To do this we adapted 
both the Busselton data and the 
PROCAM BN so that all correspond-
ing variables match. For example, 
some of the Busselton variables are 
measured on a different scale, or do 
not conform precisely to those in the 
PROCAM model.  Details are in 
Twardy et al. (2005).  Henceforth we 
will refer to the adapted Busselton 
dataset as the Busselton-PROCAM 
dataset. 
The adapted PROCAM network will 
work on the Busselton-PROCAM data. 
However, it uses the original 
PROCAM priors from their German 
population, so even if the risk equa-
tion is exactly right for the Busselton 
population, the adapted PROCAM BN 
may perform badly if the baseline 
population is different. For that rea-
son, we modified the priors to match 
the distribution in the 1978 cohort, 
using the Lauritzen & Spiegelhalter 
method (Lauritzen and Spiegelhalter, 
1988) based on frequencies. 
4 Learning CHD BNs 
CaMML (Wallace and Korb, 1999; 
Wallace et al., 2005) is a causal BN 
learner. It attempts to learn the best 
causal structure to account for obser-
vational data, using a minimum mes-
sage length (MML) metric with an 
MCMC search over the model space. 
MML provides a Bayesian informa-
tion-theoretic metric, making a tradeoff 
between prior probability (model com-
plexity) and goodness of fit, thereby 
avoiding overfitting the data. Across a 
range of problems, CaMML has 
matched the best alternative programs 
(Neil et al., 1999; Neil and Korb, 1999; 
Dai et al., 1997). 
In this work we apply two different 
versions of CaMML, one which learns 
linear path models (Wallace and Korb, 
1999; Korb and Nicholson, 2004) and 
another which learns discrete BNs 
(Korb and Nicholson, 2004; Wallace 
et al., 2005).1  Since linear CaMML 
uses numerical variables it does not 
need to discretize when learning, of 
course. As it has to learn only one pa-
rameter per arc, it is more efficient and 
less likely to omit connections because 
of insufficient data. However, for test-
ing using the Weka machine learning 
environment (Witten and Frank, 2000), 
we needed to discretize the variables, 
so we used the Weka-provided MDL 
discretizer, which attempts to find an 
optimal discretization for each continu-
ous variable as the sole predictor of 
the target. Where CaMML is finding 
multiple parents for the target such a 
discretization is suboptimal; enhanc-
ing CaMML with better discretization 
remains a task for the future. 
We also had to make choices regard-
ing the handling of missing values. For 
linear CaMML, missing values were 
removed.  For discrete CaMML, three 
alternatives were investigated.  First, 
model missing values as a new value, 
namely, “missing”. This allows us to 
discover whether missingness is related 
to other states of the network. How-
ever, there are drawbacks to such 
modeling. The extra state makes each 
CPT more costly to state and harder to 
parameterize. The second method is 
to impute (replace) missing values with 
the mean.  The final alternative we used 
is to remove cases with missing val-
1 CaMML has been developed at Monash University by the late Professor Chris Wallace and others, including 
the authors, over a number of years. It is not a commercial product, nor is it  GPL, and users may not view the 
source without prior permission. However, the various versions are available for experimentation and testing. 
See http://www.datamining.monash.edu.au/software/camml/ for information on obtaining CaMML. Twardy et al. | electronic Journal of Health Informatics 1(1): e3 
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ues. 
We now look at models learned by 
CaMML. We want to find the best 
causal model over our variables. In 
principle, we run CaMML and use its 
best model. However, what CaMML 
reports as best can be misleading: it 
may have the highest posterior prob-
ability and yet be highly unlikely. To 
aid our interpretation, we can make a 
“summary model” showing each arc 
that appeared more than, say, 10% of 
the time, with more frequent arcs drawn 
more boldly.  The idea for this sum-
mary graph was taken from (Smith et 
al., 2003). We can then be very confi-
dent of arcs that appear nearly all (or 
none) of the time, though not always 
their direction. 
4.1 BNs learned by discrete 
CaMML 
First we ran discrete CaMML on the 
whole of the Busselton-PROCAM 
dataset (see above Section 3.5).  Fig-
ure 5 shows three summary graphs 
showing arc frequencies for the three 
methods of handling missing data: (a) 
modeling missing explicitly; (b) im-
puting mean (or mode) values; and (c) 
removing missing values. Thicker arcs 
indicate higher frequencies. Although 
there are some variations depending 
on how we treat missing values, we 
note that CHD10 is never directly con-
nected to SBP, Diabetes, or Smoking. 
Conversely, CHD10 is always linked 
to Age, and when not modeling miss-
ing, also to HDL and LDL. 
4.2 BNs learned by linear 
CaMML 
We removed the missing cases (leav-
ing 1,416 out of 1,842 cases) and 
learned a linear model. The resulting 
model is shown in Figure 6(a), and a 
summary graph in Figure 6(b). Once 
again, we see that CHD10 is strongly 
associated with Age and HDL, but not 
much else. Age has a strong positive 
effect on CHD10, and HDL has a mod-
erate negative effect.  Although the 
causal directions must be viewed 
skeptically, we can see that SBP has a 
mixed effect. High SBP “raises” Age, 
which raises CHD10. However, high 
SBP also “raises” HDL, thereby low-
ering CHD10. This model agrees with 
the previous ones that Smoking and 
Diabetes are related to CHD10 only 
through other variables.  We should 
not draw any conclusions about Tri, 
since it is not well-modeled by a 
Gaussian distribution. 
4.3 CaMML on all variables 
We also ran CaMML over the com-
plete Busselton variable set (for the 
1978 cohort), which adds Height, 
Weight, DBP, SmokeAmt, Drinker, and 
AlcAmt to the variables of Busselton- 
PROCAM. To simplify matters, and 
to allow for some direct comparison 
with the smaller models, we use data 
for males only, unbold Sex. (N approx. 
equals 1,820). 
Figure 7 shows the results for dis-
crete CaMML, removing all missing 
cases. As the search space is much 
larger, we used 100 times the default 
search length. (For models with linear 
CaMML, on the entire Busselton 
dataset, see Twardy et al., 2005.) Look-
ing at the summary graph and the best 
model (Figure 7(a) & (b)), we see that 
given Age and Total Cholesterol, the 
new variables do not help very much 
for predicting CHD10. However, in the 
best model, drinking raises HDL 
(good) cholesterol. Intervening on 
Drinking (to prevent additional corre-
lations from the “back paths” through 
Age) we find the probability of high 
HDL (> .3 mmol/L) is 0.4 for non-
drinkers, but 0.6 for drinkers. How-
ever, in this model, that will have no 
effect on anything else, because there 
are no variables “downstream” of 
HDL. 
5 Experimental 
Evaluation 
So far we have presented some BNs 
knowledge engineered from the litera-
ture and some CaMML discovered 
BNs. How good are these models? 
Figure 5: Three summary graphs showing arc frequencies for BNs produced by dicrete CaMML from the 
Busselton PROCAM dataset. (a) Modeling missing; (b) Imputing mean (or mode) values; (c) Removing 
missing. 
Key: (#arcs/10)   . . . 1-2      - - - 3-5     – 6-8       — 9-10   
(a)  (b)  (c) 
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How well do they fit the data? Are they 
able to get the right answer on most of 
the cases, or the most important cases? 
And, do they overfit the data, leading 
to poor generalization? The question 
of goodness of fit is easy to answer: 
we evaluate the models on one or more 
measures of fit, such as the area under 
ROC curves. 
The question of generalization is 
harder to answer, since the only avail-
able data for testing both the Busselton 
and CaMML BNs are those used to 
develop them.  We partition the data 
into n sets of equal size, and in turn 
make each the test set for models 
learned on the remaining n-1, giving 
us n experiments. If n is too small we 
have little confidence that our runs are 
representative; if too large we intro-
duce too much correlation among the 
training sets for each of the n runs, 
misleading us into thinking we have 
less variance than we really do. 
Dietterich (1998) argues that 10-fold 
cross-validation is about right, though 
he also offers a more conservative 
“5x2-fold” variant. 
To further reduce variance we use 
stratified samples, meaning the 10 
“folds” all have about the same pro-
portion of positive and negative CHD 
events. This is roughly equivalent to 
stratified random samples in clinical 
trials.  Once we determine which in-
ference procedure (machine learner) 
does best on such holdout tests, it can 
then be used on the full dataset. 
5.1 Metrics and Candidates 
The results show two metrics: ROC 
curves and Bayesian Information Re-
ward (BIR).2 An ROC curve shows 
how quickly our true positives go up 
Figure 6: The PROCAM Busselton path model, as found by Linear CaMML. (a) the best model (weights are 
path coefficients, dashed indicates dubious arc); (b) the summary graph. 
(a)  (b) 
Figure 7: The BN for the whole Busselton dataset, Males only. (a) the “best” model; (b) the summary graph. 
(a)  (b) 
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as we allow more false positives. The 
closer the curve to the upper left, the 
better the “gain”. The area under the 
curve (AUC) averages the performance 
of the learner, with a perfect learner 
having AUC=1 and a random predic-
tor having AUC=0.5 (a diagonal line). 
BIR (Hope and Korb, 2004) is one of 
the log loss family of metrics, reward-
ing learners not just for right/wrong, 
but also for getting the probability of 
an event correct (i.e., calibration). It’s 
a Bayesian metric, taking prior prob-
abilities into account and maximally 
rewarding algorithms which best esti-
mate the posterior probability distri-
bution over predicted events. 
In the first set of experiments, we 
compare the knowledge engineered 
BNS (see Section 3) and the BN 
learned by CaMML when removing 
missing data (see Section 4). The three 
knowledge-engineered BNS are 
Busselton, PROCAM-German (origi-
nal German priors) and PROCAM- 
adapted (Busselton priors). Note: this 
BN is learned from the entire data set, 
just as the Busselton and PROCAM 
models were learned on their respec-
tive full datasets. 
In the second set of experiments, we 
compared CaMML against the stand-
ard machine-learning algorithms pro-
vided by Weka: Naive Bayes, J48 
(C4.5), AODE, logistic regression, and 
an artificial neural network (ANN) (all 
run with default settings).  For com-
parison, we also included Perfect (al-
ways guesses the right answer with full 
confidence) and Prior (always guesses 
the training prior), which should set 
the upper and lower bounds on rea-
sonable performance, respectively. 
5.2 Results 
Figure 8 shows the ROC curves and 
BIR results for the BNs on the 
Busselton-PROCAM data. The two 
PROCAM BNs score the same AUC 
(0.845).  Interestingly, CaMML does 
just as well, though we know that it 
uses only four variables to predict 
CHD10!  The Busselton BN no longer 
matches the transformed variables in 
the Busselton-PROCAM dataset, yet 
it still manages a respectable AUC of 
0.828. 
Figure 9 shows how CaMML and 
standard machine learners fare on the 
Busselton-PROCAM data. Logistic re-
gression does well with AUC of 0.844 
and a BIR clearly above zero. None of 
the other learners did as well on ROC. 
The next best AUC was Naive Bayes 
at 0.828. However, Naive Bayes does 
very poorly on BIR, with scores indis-
tinguishable from the prior. CaMML 
and AODE also do well on BIR, (other 
methods of handling missing values 
averaged about the same, with slightly 
less variance).  They perform about 
the same on AUC, scoring about 0.81. 
J48 (C4.5) did quite poorly. 
We repeated the previous experi-
ment, but used the original Busselton 
dataset, males only. The results (not 
2 We have also looked at accuracy, log loss and quadratic loss, but do not include here for reasons of space. 
The results are much the same. 
Figure 8: Evaluating the BNs on the Busselton-PROCAM dataset: (a) 
ROC curves and AUC; (b) BIR cross-validation results. 
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shown here for reasons of space) are 
much as before, only the Busselton BN 
now does better, and the other models 
do worse, so the Busselton and 
PROCAM BNs get AUC approx. 
equals 0.83. 
6 Conclusion 
We found that the PROCAM BN 
(German priors) does as well as a lo-
gistic regression model of the 
Busselton data, which is otherwise the 
best model. They had the same AUC, 
with about the same curve. This means 
they ranked cases in roughly the same 
order.  However, we also found that 
the PROCAM BN did just as well as 
the logistic regression on BIR and re-
lated metrics, which suggests that it is 
well-calibrated, regardless of the fact 
that the individual regression coeffi-
cients might be different. 
We question the technique of com-
paring relative risk by simply compar-
ing the coefficients. This presumes that 
the coefficients are individually mean-
ingful; whereas there may be alterna-
tive distinct sets of coefficients which 
perform equally well in prediction. 
We have made an initial effort in 
Bayesian network modeling of CHD 
epidemiological data, developing one 
set of networks from the literature and 
another using a causal discovery algo-
rithm.  These models perform as well 
as anything reported thus far. 
When run in BN modeling software 
(Netica), these models provide a sim-
ple GUI interface and, in the case of 
those developed from the literature, 
they tell an intuitive causal story of 
CHD risk. This provides an opportu-
nity to make these models accessible 
to clinicians. Particularly attractive in 
this regard is the ready ability to ex-
tend the models for decision making, 
incorporating testing and health costs 
and the explicit modeling of health in-
terventions (see Korb et al., 2004). The 
combination allows for a simple in-
vestigation of hypothetical interven-
tions and their comparative prognoses 
and costs. 
Nevertheless, logistic regression 
models so far do at least as well as our 
Bayesian networks in testing, if not in 
usability. We expect the major advan-
tages of the introduction of Bayesian 
networks to be seen in future work. 
We are currently developing causal 
discovery tools allowing the combina-
tion of discrete and continuous vari-
ables in the learning process. 
Furthermore, we are enhancing 
CaMML’s ability to guide its search 
using prior expert knowledge. These 
efforts should result in improved mod-
els of CHD in the future. 
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Figure 9: Evaluating the CaMML BNs and the standard machine 
learners on the Busselton-PROCAM dataset: (a) ROC curves and AUC: 
(b) BIR cross-validation results. 
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